Xerox ECP- Magenta Toner Premix/Concentrate for ECP 42 Material Safety Data Sheet

XEROX
Supplier:
Xerox Corporation
Rochester, NY 14644
Trade Names/Synonyms: ECP- Magenta Toner Premix/Concentrate for ECP 42
Chemical Name:
WHMIS Status:
Ingredients (% by wt.)
Isoparaffinic hydrocarbon solvent (80-100%)
Polymer (<2%)
Pigment (<2%)
Primary Route of Entry:
Inhalation
Eyes:
Flush with water for 15 minutes. If irritation persist, call a physician. dizziness anesthesia, drowsiness, unconsciousness, and
Skin:
Wash with soap and water. If skin is broken, call a physician.
Inhalation:
Remove from exposure.
Ingestion:
DO NOT induce vomiting, call a physician immediately.
This material has been evaluated by Xerox Corporation. The toxicity data noted below is for isoparaffinic hydrocarbons and similar
i nks.
Oral LD : >10 g/kg (rat) practically non-toxic.
50
Dermal LD : >3.2 g/kg (rabbit) practically non-toxic.
50
Inhalation LC : >2000 ppm/4 hr (rat); >1800 ppm/6 hr (monkey) practically non-toxic.
50
Eye Irritation: May cause irritation.
Skin Sensitization: Not a sensitizer.
Skin Irritation: Not an irritant.
Human Patch: Non-sensitizing. May cause irritation and dermatitis with prolonged or repeated contact.
Mutagenicity: No mutagenicity detected in Ames, Pol A+/A-, WP
Exchange, Dominant Lethal and Micronucleus Assays.
Carcinogens: None present
Aquatic LC : None available
50
Additional Information:
•
Isoparaffinic hydrocarbon solvent has a low order of acute oral and dermal toxicity, but minute amounts aspirated into the lungs
during ingestion or vomiting may cause mild to severe pulmonary injury, including fatality.
•
Rat inhalation at 900 ppm not fetotoxic or teratogenic.
1
The product does not contain a toxic chemical(s) subject to the reporting requirements of Section 313 of Title III of the Superfund Amendments and Reauthorization
Act of 1986 and 40CFR Part 372. Its ingredients do not appear on the California Proposition 65 List.
Canadian Domestic Substances List (DSL)
respective trade secret numbers: Massachusetts, 99-125-002 or -010; New Jersey, 800814-5000, 800814-5005, 800814-5006; and New York, 206 or 210. They are not
considered Hazardous as defined by WHMIS and a Trade Secret Exemption is not required for Canada.
N.A. - Not Applicable N.E. -None Established N.D. -Not Determined
Material Safety Data Sheet
Xerox Canada Ltd.
5650 Yonge Street
North York, Ontario M2M 4G7
Section I - Product Identification
None
Class B/Div. 3, Combustible liquid and Class D/Div. 2B, Toxic
1,2
Section II - Emergency and First Aid
Section III - Toxicology and Health Information
3
These ingredients are claimed as a trade secret by a Xerox supplier. They are registered in the following states under the
MSDS No:
Date:
Revision:
Telephone # (s): Safety Information: (800) 828-6571
Health Emergency: (585)422-2177
Transportation Emergency (Chemtrec): (800) 424-9300
Part No.: 4813-32*
CAS No.
64742-48-9
Trade Secret
Trade Secret
Symptoms of Overexposure:
High vapor concentrations (>1000 ppm) are irritating to
the eyes and respiratory tract, and may cause headaches,
other central nervous system effects, including fatality.
Medical Conditions Generally Aggravated by Exposure:
Skin contact may aggravate an existing dermatitis.
Additional Information:
None.
, Mouse Lymphoma, In Vitro Sister Chromatid
2
2
All ingredients contained within this product are listed on the
4
XEL-Xerox Exposure Limit.
A-2006A
8/14/85
1/12/07
26R351
4813-2* 26R237
4813-1-1* 26R30
4813-16* 26R30-01
4813-16-6* 26R236
4813-32-6* 26R238
*Cancelled
3
3
TLV: N.E.
PEL: N.E.
STEL: N.E.
Ceiling: N.E.
4
XEL : 200 ppm (isoparaffinic
hydrocarbon solvent)
600E30170